ORCHEV has left no stone unturned in ensuring a very close and integrated approach to its motto of providing pharmaceutical raw material for larger cause. Starting from the days where limited choice could be offered, now the product choice has increased manifold. Ranitidine is being manufactured in three grades.

The net profit of the company rose to almost 10 times within a span of just 6 years. This was achieved at a time when the whole world was facing global recession, vis-a-vis rise in price of basic inputs with low market price of final product. This leaves no doubt the guarantee of the product ORCHEV develops and its acceptablility in the international market. This also proves that ORCHEV is indeed determined to reduce the cost of the product, to ensure the quality output, with judicious deployment of fund and optimum utilization of its availbale resources. This fact is clearly evident when the production chart is closely viewed. The production has increased vis-a-vis quality.